ShangBay Capital LLC
Venture capitalPalo Alto · Seed–Series A · 13 people tracked
Investment thesis
ShangBay Capital focuses on backing founders who build disruptive companies targeting large, unmet clinical needs through novel approaches. The firm cultivates relationships with investors, entrepreneurs, KOLs, strategics, and industry innovators, and leverages a leadership team with a combined 100+ years of experience and deep ties to strategics and innovators in disruptive technologies. Its aim is to help founders address significant market needs while generating favorable returns.
Source: firm website, verified Aug 11, 2026.
Team · 13 people
from the firm's website & public directories
What they invest in
from 28 of 67 portfolio companiesHealthtech ×20Medical Devices ×18Biotech ×16Deep Tech ×7AI & Machine Learning ×2Digital Health ×2FemTech ×1Hardware ×1
HQs:United States×28
Investments · 67 tracked
founders shown can be your intro pathBy year:2025 · 12024 · 22023 · 12020 · 22019 · 12016 · 18 dated
Ceribell develops a point-of-care EEG system that uses AI to detect seizure activity, including status epilepticus, in patients.
AI & Machine LearningHealthtechMedical DevicesSunnyvale, US
Joseph Taylor(Director)Scott Blumberg(Executive Officer)Lucian Iancovici(Director)Raymond Woo(Executive Officer)Josef Parvizi(Director)David Stoffel(Executive Officer)
Luminopia develops software-based therapeutics for neuro-visual disorders that stem from deficiencies in the brain rather than the eyes, generating therapeutic visual stimuli delivered through a virtual reality headset.
BiotechDigital HealthMedical DevicesAspen, US
DEAN A. TRAVERS(Executive Officer, Director)SCOTT XIAO(Executive Officer, Director)ALEXANDER WENDLAND(Executive Officer, Director)Scott Xiao(Co-Founder & CEO)Dean Travers(Co-Founder)Brion Raymond(CBO)
Petal is developing an incisionless surgery platform using Millisecond Pulse Histotripsy, a form of focused therapeutic ultrasound that breaks down targeted diseased tissue without incisions, heat, or trauma.
BiotechDeep TechHealthtechMedical DevicesRedwood City, US
Prashant Chopra(Executive Officer, Director, Promoter)Prash Chopra(Founding CEO & Director)Bowen Jiang(Co-founder)Nicholas Theodore(Co-founder & Director)Rony Abovitz(Co-founding Advisor)
BoardFrederic Moll(Director)
Petal Surgical develops an incisionless surgery platform using Millisecond Pulse Histotripsy, a form of focused therapeutic ultrasound that breaks down targeted tissue via "Acoustic Liquefaction" without cutting, heat, or trauma.
Deep TechHealthtechMedical Devices
Prash Chopra(Founding CEO & Director)Bowen Jiang(Co-founder)Nicholas Theodore(Co-founder & Director)Frederic H. Moll(Director)Rony Abovitz(Co-founding Advisor)
Abcuro is a clinical-stage biopharmaceutical company developing ulviprubart, a monoclonal antibody that selectively depletes highly cytotoxic T cells by targeting the KLRG1 receptor.
BiotechHealthtechNewton, US
John Alexander Martin(Executive Officer, Director)Stefano Gulla(Executive Officer)Evan Thompson(Executive Officer)David de Graaf(Executive Officer, Director)Steven A. Greenberg(Chief Scientific Advisor & Co-Founder)Alex Martin(Chief Executive Officer)
BiotechMenlo Park, US
Xin Guo(Director)Dongliang Ge(Executive Officer, Director)Bo Zhang(Executive Officer, Director)
BoardWilliam Dai(Director)
BiotechCampbell, US
Henry Chen(Director)Claudio Argento(Director)Mariam Maghribi(Executive Officer, Director)Amr Salahieh(Director)Casey Gordon(Director)
Avation Medical manufactures the Vivally System, an FDA-cleared wearable device that uses transcutaneous tibial nerve stimulation to treat overactive bladder and urge urinary incontinence in at-home 30-minute sessions.
Digital HealthHealthtechMedical DevicesValencia, US
Jill Schiaparelli(Executive Officer, Director)Thomas Shehab, MD(Director)Kevin Wasserstein(Director)
Berkeley Lights (now Bruker Cellular Analysis) develops the Beacon optofluidic system for single-cell functional analysis, enabling researchers to profile live single cells to discover therapeutic antibodies, interrogate T cells, identify cell therapies, and accelerate cell line development.
BiotechDeep TechHardwareEmeryville, US
BiotechCharlottesville, US
Kevin S Eisenfrats(Executive Officer, Director, Promoter)Tom Thorpe(Director)Michael King(Director)
BoardIris Van Alderwerelt van Rosenburgh(Director)Gurdane Bhutani(Director)Martin J Emerson(Director)
Fremont, US
Erik Engelson(Director)Skott Greenhalgh(Director)
BoardMichael Wallace(Executive Officer, Director)
FemDx Medsystems is a medical device company developing minimally invasive technologies for diagnosing and treating gynecological conditions, with a focus on reproductive health and gynecological cancers.
FemTechHealthtechMedical Devices
Fluid Biomed develops the ReSolv stent, a hybrid polymer-metal, self-expanding flow-diverting stent designed to treat brain aneurysms and reduce the risk of rupture and stroke.
BiotechHealthtechMedical Devices
IgGenix is a clinical-stage biotechnology company focused on antibody discovery and development for allergies and immunological diseases.
AI & Machine LearningBiotechHealthtechSouth San Francisco, US
Kari Nadeau(Scientific Co-Founder)
Immune Onc is a biotechnology company developing medicines to treat patients with hard-to-treat cancers and autoimmune diseases, with expertise in translational medicine and clinical development.
BiotechMedical DevicesPalo Alto, US
Xiaoling Charlene Liao(Executive Officer, Director)Guo-Liang Yu(Director)Liqun Luo(Director)
Laplace Interventional develops a transcatheter tricuspid valve replacement system that delivers a prosthetic valve percutaneously, avoiding open-heart surgery for patients with tricuspid regurgitation.
HealthtechMedical DevicesPlymouth, US
Ramji Iyer(Executive Officer, Director)
BoardJenny H. Barba(Director)Todd Mortier(Director)Colin Morrison(Director)
Lucira Health manufactures portable diagnostic devices that connect to smartphones to test bodily fluids for infectious diseases, enabling rapid results outside of clinical settings.
BiotechHealthtechMedical DevicesEmeryville, US
Debkishore Mitra(Founder)inSteve Tablak(Director)Justin Butler(Director)Tuff Yen(Director)John R. Waldeisen(Director)
BoardErik T. Engelson(Executive Officer, Director)
Magnetic Insight develops magnetic particle imaging technology that uses non-radioactive tracers as an alternative to conventional radioactive tracers used in nuclear medicine scans.
Deep TechHealthtechMedical Devices
Mediartx develops novel therapies for patients with fibrotic diseases.
BiotechMedical DevicesBoston, US
Rahul Ballal, PhD(CEO)Paul Yaworsky, PhD(CSO)inRahul Ballal(Executive Officer, Director)Brian Hubbard(Director)Stacey Brenner(Executive Officer)David de Graaf(Director)
NeuroVasc Technologies develops catheter-based medical devices designed to treat stroke and other neurological conditions.
Deep TechHealthtechMedical DevicesCalifornia, US
JEFF PETERS(Director)LU GANG(Director)DAVE FERRERA(Director)JIANLU MA(Executive Officer, Director)
BoardWILLIAM DAI(Director)
California-based surgical robotics company focused on endoluminal robotics.
HealthtechCambridge, US
James A. Stefater(Executive Officer)Michael Singer(Director)Richel Liu(Director)Thomas P. Stryjewski(Director)Sameer Sabir(Director)Carl Berke(Director)
SetPoint Medical develops an implantable wireless device that stimulates the vagus nerve to reduce inflammation and treat rheumatoid arthritis through a neuroimmune modulation approach.
BiotechHealthtechMedical DevicesValencia, US
Developing SKY-0515 for Huntington's Disease; running the global pivotal FALCON-HD clinical trial.
Develops a non-invasive solution using alternating magnetic field technology to treat infected metallic implants by eradicating biofilms.
College Station, US
James Y Lancaster(Executive Officer, Director)John Hodock(Director)Robert Calvin Goforth(Director)
Sonovascular is developing an interventional treatment for venous thromboembolism (VTE) that uses microbubble-mediated cavitation, delivered as a cath lab-based procedure without requiring ICU treatment.
BiotechHealthtechMedical DevicesChapel Hill, US
William N. Starling(Director)Daniel Estay(Executive Officer, Director)
Irvine, US
Ken Wang(Executive Officer, Director)Dongping Lin(Executive Officer, Director)Matt Margolies(Executive Officer, Director)Jing Zhang(Director)Bo Li(Director)Xiansheng Duan(Director)
Exits · 2
IPOs and acquisitions across the tracked portfolioCeribellNASDAQ: CBLLTvardi TherapeuticsNASDAQ: TVRD
Portfolio news
latest coverage across their companiesContraline · medcitynews.com · Jun 5, 2026
Nervonik · citybiz.co · Apr 28, 2026
Frequently asked questions
- What stage does ShangBay Capital LLC invest at?
- ShangBay Capital LLC invests at the Seed, Series A stages.
- What sectors does ShangBay Capital LLC focus on?
- ShangBay Capital LLC focuses on Biotech, Healthtech, Medical Devices.
- Where is ShangBay Capital LLC located?
- ShangBay Capital LLC is headquartered in Palo Alto, US.
Co-investors · 7
Norwest is a venture and growth equity investment firm that has backed over 700 companies across sectors including AI, retail, and healthcare, working alongside entrepreneurs from early to late-stage growth.
US Venture Partners (USVP) is an early-stage venture capital firm investing in information technology and healthcare companies, with four decades of investing experience.
Sony Innovation Fund is split into several separate funds instead of one, including an early-stage fund run directly by Sony, a growth-stage fund with Daiwa, a climate-focused fund, an Africa entertainment fund, and later-stage funds through Sony Ventures, with investment decisions made by a committee that includes corporate executives and business division heads; it doesn't require startups to work with Sony, though about 40% end up collaborating with the company in some way across areas like gaming, semiconductors, electronics, music, film, and finance. The fund has backed unusual, frontier-type companies like an odor digitization startup, a sampling-rights marketplace, an AR display company, and a heart-failure regenerative medicine company, and its leaders describe the work as end-to-end business incubation covering sourcing, diligence, execution, value enhancement, monitoring, and exit rather than just providing capital.
Action Potential Venture Capital is a corporate venture fund backed by GSK that invests in peripheral neuromodulation medical devices and bioelectronics technologies.
Alumni Ventures (AV) is a venture firm that gives accredited individual investors access to professionally managed, diversified venture portfolios by co-investing alongside leading lead VC firms. It offers annual funds, syndicate deal-by-deal investing, and various investor clubs.
Morgenthaler is a venture capital and private equity firm that has focused on building valuable companies for over 40 years.
Amplitude Venture Capital is a Canadian venture firm that creates, builds, and grows precision medicine companies aimed at improving patient outcomes.
Firms observed investing alongside ShangBay Capital LLC, from public investor directories. Shared companies are the overlap with ShangBay Capital LLC's recorded portfolio.
Similar investors
Capricorn Venture Partners is a European investment firm managing several thematic funds across growth capital, healthcare, and cleantech, as well as a combined private/quoted investment vehicle.
Eight Roads Ventures is a venture capital firm that backs and partners with technology and healthcare companies.
Granatus Ventures is a venture capital firm that backs startups worldwide leveraging Armenia's potential as an emerging technology hub.
Kleiner Perkins is a venture capital firm that backs founders across technology and life sciences, with a portfolio of companies from early stage through growth.
Sunstone Life Science Ventures is an independent European venture capital firm focused on early-stage life science companies developing novel therapeutics for humans.